Factors  ||| S:0 E:8 ||| NNS
contributing  ||| S:8 E:21 ||| VBG
to  ||| S:21 E:24 ||| TO
plasma  ||| S:24 E:31 ||| VB
TCO2  ||| S:31 E:36 ||| NNP
and  ||| S:36 E:40 ||| CC
acid-base  ||| S:40 E:50 ||| JJ
state  ||| S:50 E:56 ||| NN
in  ||| S:56 E:59 ||| IN
Ontario  ||| S:59 E:67 ||| NNP
Standardbred  ||| S:67 E:80 ||| NNP
racehorses  ||| S:80 E:91 ||| VBD
Standardbred  ||| S:91 E:104 ||| NNP
and  ||| S:104 E:108 ||| CC
Thoroughbred  ||| S:108 E:121 ||| NNP
racehorses  ||| S:121 E:132 ||| NNS
around  ||| S:132 E:139 ||| IN
the  ||| S:139 E:143 ||| DT
world  ||| S:143 E:149 ||| NN
are  ||| S:149 E:153 ||| VBP
tested  ||| S:153 E:160 ||| VBN
for  ||| S:160 E:164 ||| IN
performance  ||| S:164 E:176 ||| NN
enhancing  ||| S:176 E:186 ||| VBG
substances ||| S:186 E:196 ||| NNS
.  ||| S:196 E:198 ||| .
Among  ||| S:198 E:204 ||| IN
these  ||| S:204 E:210 ||| DT
are  ||| S:210 E:214 ||| VBP
blood  ||| S:214 E:220 ||| NN
alkalising  ||| S:220 E:231 ||| NN
substances  ||| S:231 E:242 ||| NNS
that  ||| S:242 E:247 ||| WDT
raise  ||| S:247 E:253 ||| VBP
plasma  ||| S:253 E:260 ||| JJ
pH  ||| S:260 E:263 ||| JJ
and  ||| S:263 E:267 ||| CC
total  ||| S:267 E:273 ||| JJ
carbon  ||| S:273 E:280 ||| NN
dioxide  ||| S:280 E:288 ||| NN
( ||| S:288 E:289 ||| -LRB-
TCO ||| S:289 E:292 ||| NNP
( ||| S:292 E:293 ||| -LRB-
2 ||| S:293 E:294 ||| LS
) ||| S:294 E:295 ||| -RRB-
)  ||| S:295 E:297 ||| -RRB-
concentration ||| S:297 E:310 ||| NN
.  ||| S:310 E:312 ||| .
However ||| S:312 E:319 ||| RB
,  ||| S:319 E:321 ||| ,
many  ||| S:321 E:326 ||| JJ
horses  ||| S:326 E:333 ||| NNS
have  ||| S:333 E:338 ||| VBP
an  ||| S:338 E:341 ||| DT
elevated  ||| S:341 E:350 ||| JJ
TCO ||| S:350 E:353 ||| NNP
( ||| S:353 E:354 ||| -LRB-
2 ||| S:354 E:355 ||| LS
)  ||| S:355 E:357 ||| -RRB-
due  ||| S:357 E:361 ||| JJ
to  ||| S:361 E:364 ||| TO
dietary ||| S:364 E:371 ||| VB
,  ||| S:371 E:373 ||| ,
environmental  ||| S:373 E:387 ||| JJ
and  ||| S:387 E:391 ||| CC
health  ||| S:391 E:398 ||| NN
concerns  ||| S:398 E:407 ||| NNS
without  ||| S:407 E:415 ||| IN
having  ||| S:415 E:422 ||| VBG
been  ||| S:422 E:427 ||| VBN
administered  ||| S:427 E:440 ||| VBN
an  ||| S:440 E:443 ||| DT
alkalising  ||| S:443 E:454 ||| JJ
substance ||| S:454 E:463 ||| NN
.  ||| S:463 E:465 ||| .
The  ||| S:465 E:469 ||| DT
purposes  ||| S:469 E:478 ||| NNS
of  ||| S:478 E:481 ||| IN
this  ||| S:481 E:486 ||| DT
study  ||| S:486 E:492 ||| NN
were  ||| S:492 E:497 ||| VBD
to  ||| S:497 E:500 ||| TO
determine  ||| S:500 E:510 ||| VB
the  ||| S:510 E:514 ||| DT
acid-base  ||| S:514 E:524 ||| JJ
profile  ||| S:524 E:532 ||| NN
of  ||| S:532 E:535 ||| IN
a  ||| S:535 E:537 ||| DT
cross  ||| S:537 E:543 ||| JJ
section  ||| S:543 E:551 ||| NN
of  ||| S:551 E:554 ||| IN
Standardbred  ||| S:554 E:567 ||| NNP
horses  ||| S:567 E:574 ||| NNS
in  ||| S:574 E:577 ||| IN
racing ||| S:577 E:583 ||| VBG
/ ||| S:583 E:584 ||| CD
race  ||| S:584 E:589 ||| NN
training  ||| S:589 E:598 ||| NN
in  ||| S:598 E:601 ||| IN
Ontario  ||| S:601 E:609 ||| NNP
and  ||| S:609 E:613 ||| CC
the  ||| S:613 E:617 ||| DT
main  ||| S:617 E:622 ||| JJ
independent  ||| S:622 E:634 ||| JJ
variables  ||| S:634 E:644 ||| NNS
that  ||| S:644 E:649 ||| WDT
contributed  ||| S:649 E:661 ||| VBD
to  ||| S:661 E:664 ||| TO
acid-base  ||| S:664 E:674 ||| JJ
state ||| S:674 E:679 ||| NN
.  ||| S:679 E:681 ||| .
On  ||| S:681 E:684 ||| IN
nonracing  ||| S:684 E:694 ||| JJ
days ||| S:694 E:698 ||| NNS
,  ||| S:698 E:700 ||| ,
blood  ||| S:700 E:706 ||| NN
from  ||| S:706 E:711 ||| IN
211  ||| S:711 E:715 ||| CD
horses  ||| S:715 E:722 ||| NNS
at  ||| S:722 E:725 ||| IN
rest ||| S:725 E:729 ||| NN
,  ||| S:729 E:731 ||| ,
from  ||| S:731 E:736 ||| IN
9  ||| S:736 E:738 ||| CD
training  ||| S:738 E:747 ||| NN
facilities ||| S:747 E:757 ||| NNS
,  ||| S:757 E:759 ||| ,
was  ||| S:759 E:763 ||| VBD
analysed  ||| S:763 E:772 ||| VBN
within  ||| S:772 E:779 ||| IN
30  ||| S:779 E:782 ||| CD
min  ||| S:782 E:786 ||| NN
for  ||| S:786 E:790 ||| IN
plasma  ||| S:790 E:797 ||| JJ
pH  ||| S:797 E:800 ||| NN
( ||| S:800 E:801 ||| -LRB-
7.406  ||| S:801 E:807 ||| NNP
±  ||| S:807 E:809 ||| NNP
0.039 ||| S:809 E:814 ||| NNP
;  ||| S:814 E:816 ||| :
mean  ||| S:816 E:821 ||| VB
±  ||| S:821 E:823 ||| CD
s.e. ||| S:823 E:827 ||| CD
) ||| S:827 E:828 ||| -RRB-
,  ||| S:828 E:830 ||| ,
PCO ||| S:830 E:833 ||| NNP
( ||| S:833 E:834 ||| -LRB-
2 ||| S:834 E:835 ||| LS
)  ||| S:835 E:837 ||| -RRB-
( ||| S:837 E:838 ||| -LRB-
50.0  ||| S:838 E:843 ||| CD
±  ||| S:843 E:845 ||| CD
3.4  ||| S:845 E:849 ||| CD
mmHg ||| S:849 E:853 ||| NN
) ||| S:853 E:854 ||| -RRB-
,  ||| S:854 E:856 ||| ,
from  ||| S:856 E:861 ||| IN
which  ||| S:861 E:867 ||| WDT
[ ||| S:867 E:868 ||| -LRB-
HCO ||| S:868 E:871 ||| NNP
( ||| S:871 E:872 ||| -LRB-
3 ||| S:872 E:873 ||| LS
) ||| S:873 E:874 ||| -RRB-
( ||| S:874 E:875 ||| -LRB-
- ||| S:875 E:876 ||| NNP
) ||| S:876 E:877 ||| -RRB-
]  ||| S:877 E:879 ||| -RRB-
( ||| S:879 E:880 ||| -LRB-
31.2  ||| S:880 E:885 ||| CD
±  ||| S:885 E:887 ||| CD
2.8  ||| S:887 E:891 ||| CD
mmol ||| S:891 E:895 ||| CD
/ ||| S:895 E:896 ||| CD
l ||| S:896 E:897 ||| CD
)  ||| S:897 E:899 ||| -RRB-
and  ||| S:899 E:903 ||| CC
[ ||| S:903 E:904 ||| -LRB-
TCO ||| S:904 E:907 ||| NNP
( ||| S:907 E:908 ||| -LRB-
2 ||| S:908 E:909 ||| LS
) ||| S:909 E:910 ||| -RRB-
]  ||| S:910 E:912 ||| -RRB-
( ||| S:912 E:913 ||| -LRB-
33.1  ||| S:913 E:918 ||| CD
±  ||| S:918 E:920 ||| CD
2.9  ||| S:920 E:924 ||| CD
mmol ||| S:924 E:928 ||| CD
/ ||| S:928 E:929 ||| CD
l ||| S:929 E:930 ||| NNS
;  ||| S:930 E:932 ||| :
range  ||| S:932 E:938 ||| NN
25.66-42.9 ||| S:938 E:948 ||| CD
)  ||| S:948 E:950 ||| -RRB-
were  ||| S:950 E:955 ||| VBD
calculated ||| S:955 E:965 ||| VBN
.  ||| S:965 E:967 ||| .
From  ||| S:967 E:972 ||| IN
these ||| S:972 E:977 ||| DT
,  ||| S:977 E:979 ||| ,
a  ||| S:979 E:981 ||| DT
subset  ||| S:981 E:988 ||| NN
of  ||| S:988 E:991 ||| IN
161  ||| S:991 E:995 ||| CD
horses  ||| S:995 E:1002 ||| NNS
had  ||| S:1002 E:1006 ||| VBD
full  ||| S:1006 E:1011 ||| JJ
data  ||| S:1011 E:1016 ||| NN
sets  ||| S:1016 E:1021 ||| NNS
for  ||| S:1021 E:1025 ||| IN
plasma  ||| S:1025 E:1032 ||| JJ
protein  ||| S:1032 E:1040 ||| NN
and  ||| S:1040 E:1044 ||| CC
strong  ||| S:1044 E:1051 ||| JJ
ion  ||| S:1051 E:1055 ||| JJ
concentrations ||| S:1055 E:1069 ||| NNS
.  ||| S:1069 E:1071 ||| .
These  ||| S:1071 E:1077 ||| DT
data  ||| S:1077 E:1082 ||| NNS
were  ||| S:1082 E:1087 ||| VBD
further  ||| S:1087 E:1095 ||| JJ
analysed  ||| S:1095 E:1104 ||| NN
by  ||| S:1104 E:1107 ||| IN
facility  ||| S:1107 E:1116 ||| NN
and  ||| S:1116 E:1120 ||| CC
level  ||| S:1120 E:1126 ||| NN
of  ||| S:1126 E:1129 ||| IN
TCO ||| S:1129 E:1132 ||| NNP
( ||| S:1132 E:1133 ||| -LRB-
2 ||| S:1133 E:1134 ||| LS
) ||| S:1134 E:1135 ||| -RRB-
.  ||| S:1135 E:1137 ||| .
Data  ||| S:1137 E:1142 ||| NNS
on  ||| S:1142 E:1145 ||| IN
nutrition ||| S:1145 E:1154 ||| NN
,  ||| S:1154 E:1156 ||| ,
training ||| S:1156 E:1164 ||| NN
,  ||| S:1164 E:1166 ||| ,
racing  ||| S:1166 E:1173 ||| VBG
and  ||| S:1173 E:1177 ||| CC
medications  ||| S:1177 E:1189 ||| NNS
were  ||| S:1189 E:1194 ||| VBD
also  ||| S:1194 E:1199 ||| RB
collected ||| S:1199 E:1208 ||| VBN
.  ||| S:1208 E:1210 ||| .
There  ||| S:1210 E:1216 ||| EX
were  ||| S:1216 E:1221 ||| VBD
significant  ||| S:1221 E:1233 ||| JJ
differences  ||| S:1233 E:1245 ||| NNS
amongst  ||| S:1245 E:1253 ||| IN
facilities  ||| S:1253 E:1264 ||| NNS
with  ||| S:1264 E:1269 ||| IN
respect  ||| S:1269 E:1277 ||| NN
to  ||| S:1277 E:1280 ||| TO
plasma  ||| S:1280 E:1287 ||| VB
pH ||| S:1287 E:1289 ||| JJ
,  ||| S:1289 E:1291 ||| ,
TCO ||| S:1291 E:1294 ||| NNP
( ||| S:1294 E:1295 ||| -LRB-
2 ||| S:1295 E:1296 ||| LS
) ||| S:1296 E:1297 ||| -RRB-
,  ||| S:1297 E:1299 ||| ,
strong  ||| S:1299 E:1306 ||| JJ
ion  ||| S:1306 E:1310 ||| JJ
difference  ||| S:1310 E:1321 ||| NN
( ||| S:1321 E:1322 ||| -LRB-
[ ||| S:1322 E:1323 ||| -LRB-
SID ||| S:1323 E:1326 ||| NNP
] ||| S:1326 E:1327 ||| -RRB-
) ||| S:1327 E:1328 ||| -RRB-
,  ||| S:1328 E:1330 ||| ,
PCO ||| S:1330 E:1333 ||| NNP
( ||| S:1333 E:1334 ||| -LRB-
2 ||| S:1334 E:1335 ||| LS
)  ||| S:1335 E:1337 ||| -RRB-
and  ||| S:1337 E:1341 ||| CC
total  ||| S:1341 E:1347 ||| JJ
weak  ||| S:1347 E:1352 ||| JJ
acid  ||| S:1352 E:1357 ||| NN
concentration  ||| S:1357 E:1371 ||| NN
( ||| S:1371 E:1372 ||| -LRB-
[ ||| S:1372 E:1373 ||| -LRB-
A ||| S:1373 E:1374 ||| NNP
( ||| S:1374 E:1375 ||| -LRB-
tot ||| S:1375 E:1378 ||| LS
) ||| S:1378 E:1379 ||| -RRB-
] ||| S:1379 E:1380 ||| CD
) ||| S:1380 E:1381 ||| -RRB-
.  ||| S:1381 E:1383 ||| .
Horses  ||| S:1383 E:1390 ||| NNS
having  ||| S:1390 E:1397 ||| VBG
the  ||| S:1397 E:1401 ||| DT
highest  ||| S:1401 E:1409 ||| JJS
TCO ||| S:1409 E:1412 ||| NNP
( ||| S:1412 E:1413 ||| -LRB-
2 ||| S:1413 E:1414 ||| LS
)  ||| S:1414 E:1416 ||| -RRB-
( ||| S:1416 E:1417 ||| -LRB-
37.0-42.9  ||| S:1417 E:1427 ||| FW
mmol ||| S:1427 E:1431 ||| FW
/ ||| S:1431 E:1432 ||| FW
l ||| S:1432 E:1433 ||| FW
,  ||| S:1433 E:1435 ||| ,
n  ||| S:1435 E:1437 ||| VBG
=  ||| S:1437 E:1439 ||| SYM
16 ||| S:1439 E:1441 ||| CD
)  ||| S:1441 E:1443 ||| -RRB-
had  ||| S:1443 E:1447 ||| VBD
significantly  ||| S:1447 E:1461 ||| RB
higher  ||| S:1461 E:1468 ||| JJR
[ ||| S:1468 E:1469 ||| -LRB-
SID ||| S:1469 E:1472 ||| NNP
]  ||| S:1472 E:1474 ||| -RRB-
( ||| S:1474 E:1475 ||| -LRB-
52.9  ||| S:1475 E:1480 ||| CD
±  ||| S:1480 E:1482 ||| CD
0.8  ||| S:1482 E:1486 ||| CD
mEq ||| S:1486 E:1489 ||| JJ
/ ||| S:1489 E:1490 ||| CD
l ||| S:1490 E:1491 ||| CD
)  ||| S:1491 E:1493 ||| -RRB-
and  ||| S:1493 E:1497 ||| CC
PCO ||| S:1497 E:1500 ||| NNP
( ||| S:1500 E:1501 ||| -LRB-
2 ||| S:1501 E:1502 ||| LS
)  ||| S:1502 E:1504 ||| -RRB-
( ||| S:1504 E:1505 ||| -LRB-
52.5  ||| S:1505 E:1510 ||| CD
±  ||| S:1510 E:1512 ||| CD
0.7  ||| S:1512 E:1516 ||| CD
mmHg ||| S:1516 E:1520 ||| NN
)  ||| S:1520 E:1522 ||| -RRB-
and  ||| S:1522 E:1526 ||| CC
relatively  ||| S:1526 E:1537 ||| RB
low  ||| S:1537 E:1541 ||| JJ
[ ||| S:1541 E:1542 ||| -LRB-
A ||| S:1542 E:1543 ||| NNP
( ||| S:1543 E:1544 ||| -LRB-
tot ||| S:1544 E:1547 ||| LS
) ||| S:1547 E:1548 ||| -RRB-
]  ||| S:1548 E:1550 ||| -RRB-
( ||| S:1550 E:1551 ||| -LRB-
14.9  ||| S:1551 E:1556 ||| CD
±  ||| S:1556 E:1558 ||| CD
0.7  ||| S:1558 E:1562 ||| CD
mEq ||| S:1562 E:1565 ||| JJ
/ ||| S:1565 E:1566 ||| CD
l ||| S:1566 E:1567 ||| CD
)  ||| S:1567 E:1569 ||| -RRB-
compared  ||| S:1569 E:1578 ||| VBN
to  ||| S:1578 E:1581 ||| TO
average  ||| S:1581 E:1589 ||| JJ
TCO ||| S:1589 E:1592 ||| NNP
( ||| S:1592 E:1593 ||| -LRB-
2 ||| S:1593 E:1594 ||| LS
)  ||| S:1594 E:1596 ||| -RRB-
( ||| S:1596 E:1597 ||| -LRB-
32.1.0-34.9  ||| S:1597 E:1609 ||| FW
mmol ||| S:1609 E:1613 ||| FW
/ ||| S:1613 E:1614 ||| FW
l ||| S:1614 E:1615 ||| FW
)  ||| S:1615 E:1617 ||| -RRB-
horses  ||| S:1617 E:1624 ||| NNS
( ||| S:1624 E:1625 ||| -LRB-
n  ||| S:1625 E:1627 ||| CD
=  ||| S:1627 E:1629 ||| SYM
75 ||| S:1629 E:1631 ||| CD
) ||| S:1631 E:1632 ||| -RRB-
.  ||| S:1632 E:1634 ||| .
In  ||| S:1634 E:1637 ||| IN
horses  ||| S:1637 E:1644 ||| NNS
with  ||| S:1644 E:1649 ||| IN
the  ||| S:1649 E:1653 ||| DT
lowest  ||| S:1653 E:1660 ||| JJS
TCO ||| S:1660 E:1663 ||| NNP
( ||| S:1663 E:1664 ||| -LRB-
2 ||| S:1664 E:1665 ||| LS
)  ||| S:1665 E:1667 ||| -RRB-
( ||| S:1667 E:1668 ||| -LRB-
n  ||| S:1668 E:1670 ||| CD
=  ||| S:1670 E:1672 ||| SYM
11 ||| S:1672 E:1674 ||| CD
)  ||| S:1674 E:1676 ||| -RRB-
the  ||| S:1676 E:1680 ||| DT
greatest  ||| S:1680 E:1689 ||| JJS
contributor  ||| S:1689 E:1701 ||| NN
was  ||| S:1701 E:1705 ||| VBD
elevated  ||| S:1705 E:1714 ||| NNS
[ ||| S:1714 E:1715 ||| -LRB-
A ||| S:1715 E:1716 ||| NNP
( ||| S:1716 E:1717 ||| -LRB-
tot ||| S:1717 E:1720 ||| LS
)  ||| S:1720 E:1722 ||| -RRB-
]  ||| S:1722 E:1724 ||| -RRB-
( ||| S:1724 E:1725 ||| -LRB-
21.0  ||| S:1725 E:1730 ||| FW
±  ||| S:1730 E:1732 ||| FW
0.7  ||| S:1732 E:1736 ||| FW
mEq ||| S:1736 E:1739 ||| FW
/ ||| S:1739 E:1740 ||| FW
l ||| S:1740 E:1741 ||| FW
)  ||| S:1741 E:1743 ||| -RRB-
and  ||| S:1743 E:1747 ||| CC
unmeasured  ||| S:1747 E:1758 ||| NNS
( ||| S:1758 E:1759 ||| -LRB-
acetate ||| S:1759 E:1766 ||| UH
,  ||| S:1766 E:1768 ||| ,
citrate ||| S:1768 E:1775 ||| NN
,  ||| S:1775 E:1777 ||| ,
proprionate ||| S:1777 E:1788 ||| NN
,  ||| S:1788 E:1790 ||| ,
butyrate ||| S:1790 E:1798 ||| CD
)  ||| S:1798 E:1800 ||| -RRB-
weak  ||| S:1800 E:1805 ||| JJ
acids  ||| S:1805 E:1811 ||| NNS
( ||| S:1811 E:1812 ||| -LRB-
7.0  ||| S:1812 E:1816 ||| CD
±  ||| S:1816 E:1818 ||| CD
0.2  ||| S:1818 E:1822 ||| CD
mEq ||| S:1822 E:1825 ||| JJ
/ ||| S:1825 E:1826 ||| CD
l ||| S:1826 E:1827 ||| CD
)  ||| S:1827 E:1829 ||| -RRB-
while  ||| S:1829 E:1835 ||| IN
[ ||| S:1835 E:1836 ||| -LRB-
SID ||| S:1836 E:1839 ||| NNP
]  ||| S:1839 E:1841 ||| -RRB-
( ||| S:1841 E:1842 ||| -LRB-
49.6  ||| S:1842 E:1847 ||| CD
±  ||| S:1847 E:1849 ||| CD
0.8  ||| S:1849 E:1853 ||| CD
mEq ||| S:1853 E:1856 ||| JJ
/ ||| S:1856 E:1857 ||| CD
l ||| S:1857 E:1858 ||| CD
)  ||| S:1858 E:1860 ||| -RRB-
and  ||| S:1860 E:1864 ||| CC
PCO ||| S:1864 E:1867 ||| NNP
( ||| S:1867 E:1868 ||| -LRB-
2 ||| S:1868 E:1869 ||| LS
)  ||| S:1869 E:1871 ||| -RRB-
( ||| S:1871 E:1872 ||| -LRB-
47.8  ||| S:1872 E:1877 ||| CD
±  ||| S:1877 E:1879 ||| CD
1.0  ||| S:1879 E:1883 ||| CD
mmHg ||| S:1883 E:1887 ||| NN
)  ||| S:1887 E:1889 ||| -RRB-
were  ||| S:1889 E:1894 ||| VBD
similar  ||| S:1894 E:1902 ||| JJ
to  ||| S:1902 E:1905 ||| TO
average  ||| S:1905 E:1913 ||| JJ
TCO ||| S:1913 E:1916 ||| NNP
( ||| S:1916 E:1917 ||| -LRB-
2 ||| S:1917 E:1918 ||| LS
)  ||| S:1918 E:1920 ||| -RRB-
horses ||| S:1920 E:1926 ||| NNS
.  ||| S:1926 E:1928 ||| .
Thirty-two  ||| S:1928 E:1939 ||| JJ
horses  ||| S:1939 E:1946 ||| NNS
had  ||| S:1946 E:1950 ||| VBD
a  ||| S:1950 E:1952 ||| DT
TCO ||| S:1952 E:1955 ||| NNP
( ||| S:1955 E:1956 ||| -LRB-
2 ||| S:1956 E:1957 ||| LS
)  ||| S:1957 E:1959 ||| -RRB-
ranging  ||| S:1959 E:1967 ||| VBG
from  ||| S:1967 E:1972 ||| IN
35.0-36.9  ||| S:1972 E:1982 ||| FW
mmol ||| S:1982 E:1986 ||| FW
/ ||| S:1986 E:1987 ||| FW
l ||| S:1987 E:1988 ||| FW
) ||| S:1988 E:1989 ||| -RRB-
.  ||| S:1989 E:1991 ||| .
There  ||| S:1991 E:1997 ||| EX
is  ||| S:1997 E:2000 ||| VBZ
a  ||| S:2000 E:2002 ||| DT
wide  ||| S:2002 E:2007 ||| JJ
range  ||| S:2007 E:2013 ||| NN
of  ||| S:2013 E:2016 ||| IN
acid-base  ||| S:2016 E:2026 ||| JJ
state  ||| S:2026 E:2032 ||| NN
and  ||| S:2032 E:2036 ||| CC
factors  ||| S:2036 E:2044 ||| NNS
contributing  ||| S:2044 E:2057 ||| VBG
to  ||| S:2057 E:2060 ||| TO
acid-base  ||| S:2060 E:2070 ||| JJ
state  ||| S:2070 E:2076 ||| NN
amongst  ||| S:2076 E:2084 ||| IN
Standardbred  ||| S:2084 E:2097 ||| NNP
race  ||| S:2097 E:2102 ||| NN
horses  ||| S:2102 E:2109 ||| NNS
in  ||| S:2109 E:2112 ||| IN
Ontario ||| S:2112 E:2119 ||| NNP
.  ||| S:2119 E:2121 ||| .
Dietary ||| S:2121 E:2128 ||| NNP
,  ||| S:2128 E:2130 ||| ,
environmental  ||| S:2130 E:2144 ||| JJ
and  ||| S:2144 E:2148 ||| CC
handling  ||| S:2148 E:2157 ||| VBG
practices  ||| S:2157 E:2167 ||| NNS
and  ||| S:2167 E:2171 ||| CC
health  ||| S:2171 E:2178 ||| NN
concerns ||| S:2178 E:2186 ||| NNS
,  ||| S:2186 E:2188 ||| ,
that  ||| S:2188 E:2193 ||| DT
elevate  ||| S:2193 E:2201 ||| JJ
plasma  ||| S:2201 E:2208 ||| NNS
[ ||| S:2208 E:2209 ||| -LRB-
SID ||| S:2209 E:2212 ||| NNP
] ||| S:2212 E:2213 ||| -RRB-
,  ||| S:2213 E:2215 ||| ,
lower  ||| S:2215 E:2221 ||| JJR
[ ||| S:2221 E:2222 ||| -LRB-
A ||| S:2222 E:2223 ||| NNP
( ||| S:2223 E:2224 ||| -LRB-
tot ||| S:2224 E:2227 ||| LS
) ||| S:2227 E:2228 ||| -RRB-
]  ||| S:2228 E:2230 ||| -RRB-
and  ||| S:2230 E:2234 ||| CC
lower  ||| S:2234 E:2240 ||| RBR
the  ||| S:2240 E:2244 ||| DT
concentration  ||| S:2244 E:2258 ||| NN
of  ||| S:2258 E:2261 ||| IN
unmeasured  ||| S:2261 E:2272 ||| JJ
weak  ||| S:2272 E:2277 ||| JJ
acids  ||| S:2277 E:2283 ||| NNS
are  ||| S:2283 E:2287 ||| VBP
the  ||| S:2287 E:2291 ||| DT
primary  ||| S:2291 E:2299 ||| JJ
contributors  ||| S:2299 E:2312 ||| NNS
to  ||| S:2312 E:2315 ||| TO
alkalosis  ||| S:2315 E:2325 ||| VB
and  ||| S:2325 E:2329 ||| CC
elevated  ||| S:2329 E:2338 ||| VBD
TCO ||| S:2338 E:2341 ||| NNP
( ||| S:2341 E:2342 ||| -LRB-
2 ||| S:2342 E:2343 ||| LS
) ||| S:2343 E:2344 ||| -RRB-
.  ||| S:2344 E:2346 ||| .
